Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0002015487-24-000003
Filing Date
2024-06-03
Accepted
2024-06-03 06:26:22
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 8132
2 SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS voting.pdf EX-1 120646
  Complete submission text file 0002015487-24-000003.txt   176228
Mailing Address 400 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 400 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-363-2400
Avinger Inc (Subject) CIK: 0001506928 (see all company filings)

EIN.: 208873453 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-88794 | Film No.: 241011924
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address 270 SHUYUN ROAD, YUHANG DISTRICT HANGZHOU F4 200000
Business Address 270 SHUYUN ROAD, YUHANG DISTRICT HANGZHOU F4 200000 8657188610082
Zylox-Tonbridge Medical Technology Co., Ltd. (Filed by) CIK: 0002015487 (see all company filings)

EIN.: 000000000 | State of Incorp.: F4 | Fiscal Year End: 1231
Type: SCHEDULE 13D/A